🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05442970
Recruiting Observational

Cohort Study for Atrial Fibrillation Risk Stratification

NCT05442970 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2013-06
Last updated
2024-05-13

Condition(s) studied

Atrial Fibrillation

Study summary

AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18 to 85 years; * Personally signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation; * Physical or psychological incapability to cooperate in the investigations

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Cardiology, University Medical Center Hamburg-Eppendorf Hamburg Germany Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05442970 on ClinicalTrials.gov ↗ ← All trials in Germany